HEAD AND NECK CANCER STAGE IV

Clinical trials for HEAD AND NECK CANCER STAGE IV explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK CANCER STAGE IV trials appear

Sign up with your email to follow new studies for HEAD AND NECK CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for Tough-to-Treat head and neck cancers

Disease control Recruiting now

This early-stage trial is testing a new combination of two experimental drugs, tislelizumab and pamiparib, given together with a standard course of chemotherapy and radiation. The goal is to find a safe and effective dose for people whose head and neck cancer has come back after …

Matched conditions: HEAD AND NECK CANCER STAGE IV

Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

HEAD AND NECK CANCER STAGE IV

Get alerted when new HEAD AND NECK CANCER STAGE IV trials appear

New hope for Tough-to-Treat head and neck cancers